Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,208 | -20,373 | -10,590 | 3,887 | -5 |
| Depreciation Amortization | 208 | 15 | 22 | 43 | -10 |
| Accounts receivable | N/A | N/A | N/A | 314 | N/A |
| Accounts payable and accrued liabilities | 201 | -450 | 669 | -60 | 7 |
| Other Working Capital | 1,494 | 1,161 | 84 | -7,235 | 7 |
| Other Operating Activity | 950 | 2,342 | 1,228 | -126 | -7 |
| Operating Cash Flow | $-15,356 | $-17,304 | $-8,589 | $-3,178 | $-7 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -29 | -60 | -1 | -12 | N/A |
| Purchase Of Investment | -25,790 | 0 | N/A | N/A | N/A |
| Sale Of Investment | 800 | 0 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 21 | 0 | 0 | 0 |
| Investing Cash Flow | $-25,018 | $-38 | $-1 | $-12 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32,716 | 16 | 48,529 | N/A | 30 |
| Other Financing Activity | 0 | -271 | -53 | 0 | 0 |
| Financing Cash Flow | $32,716 | $-255 | $48,476 | $N/A | $30 |
| Beginning Cash Position | 27,666 | 45,264 | 5,377 | 8,568 | N/A |
| End Cash Position | 20,008 | 27,666 | 45,264 | 5,377 | 23 |
| Net Cash Flow | $-7,658 | $-17,598 | $39,887 | $-3,191 | $23 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,356 | -17,304 | -8,589 | -3,178 | -7 |
| Capital Expenditure | -29 | -60 | -1 | -12 | N/A |
| Free Cash Flow | -15,385 | -17,364 | -8,590 | -3,191 | -7 |